Scientists Halt Breast Cancer Spread

February 7, 2018

Scientists have discovered that an amino acid called asparagine is essential for breast cancer spread, and by restricting it, cancer cells stopped invading other parts of the body in mice, according to research* part-funded by Cancer Research UK and published in the journal Nature today, (Wednesday). Most breast cancer patients do not die from their […]

Stand Up To Cancer Announces $11M Collaborative, Multi-Disciplinary Research Program; Microsoft Will Bring Power of AI to Investigate Immune System Response to Cancers

February 1, 2018

SANTA MONICA, Calif.–(BUSINESS WIRE)–Stand Up To Cancer (SU2C) announces today a “Convergence 2.0” research initiative that awards $11 million to seven multi-disciplinary research teams to investigate immune system response to cancers. The multi-institutional teams being announced today at SU2C’s Scientific Summit draw from the nation’s top academic research centers and will have access to Microsoft […]

Cancer ‘Vaccine’ Eliminates Tumors In Mice

February 1, 2018

Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial. Injecting minute amounts of two immune-stimulating agents directly into solid tumors in mice can eliminate all traces of cancer in the animals, including distant, untreated metastases, according to […]

Pancreatic Cancer Remains The Deadliest Major Cancer In The United States

January 5, 2018

MANHATTAN BEACH, Calif., Jan. 4, 2018 /PRNewswire-USNewswire/ — Pancreatic cancer remains the deadliest major cancer with a five-year survival of just 9 percent*, according to the Cancer Facts & Figures report released today by the American Cancer Society.   “More than 55,000 Americans – mothers, daughters, fathers, sons, colleagues and friends – will be diagnosed […]

Helix BioPharma Corp. Closes Private Placement

December 27, 2017

RICHMOND HILL, ONTARIO–(Marketwired – Dec. 22, 2017) – Helix BioPharma Corp. (TSX:HBP)(FRANKFURT:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing for gross proceeds of CAD750,600. The terms of the placement are for the purchase of units […]

Accenture and Roche Collaborate to Enhance Digital Healthcare for Cancer Patients

December 21, 2017

NEW YORK–(BUSINESS WIRE)–Accenture (NYSE: ACN) today announced a collaborative services agreement with Roche. Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.   “Tumor board coordination is labor intensive and time consuming for healthcare providers. Accenture’s global scale, deep digital expertise, and innovation […]

Certara Launches Version 17 of its PBPK Simcyp Simulator

December 5, 2017

This year’s Simcyp Simulator enhancements include new oncology and preterm-birth populations, enhanced skin and gut transporter models, and additional regulatory qualification summaries Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has launched version 17 of its Simcyp® Population-based Simulator. “We are proud to introduce several significant advances in […]